Alcohol inhibits 11-beta-hydroxysteroid dehydrogenase activity in rat kidney and liver

Hormone Research in Paediatrics

Volumn 43, Issue 5, 1995, Pages 176-180

  Valentino, R ^a   Tommaselli, A P ^b   Savastano, S ^b   Stewart, P M ^d   Ghiggi, M R ^b   Galletti, F ^c   Mariniello, P ^b   Lombardi, G ^b   Edwards, C R W ^e  

^a CNR   (Italy)

^b Chair of Endocrinology ^*  (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^e WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

11 Hydroxysteroid dehydrogenase deficiency; Alcohol; Cushing s syndrome; Mineralocorticoid activity

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; ALCOHOL; ALDOSTERONE; CORTICOSTERONE; ENZYME INHIBITOR; KIDNEY ENZYME; LIVER ENZYME; MINERALOCORTICOID;

ALCOHOL INTOXICATION; ALDOSTERONE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; FLUID INTAKE; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; URINE VOLUME; WEIGHT GAIN;

ALDOSTERONE; ANIMAL; COMPARATIVE STUDY; CORTICOSTERONE; ETHANOL; HYDROXYSTEROID DEHYDROGENASES; KIDNEY; LIVER; MALE; RATS; RATS, WISTAR; REFERENCE VALUES;

EID: 0028940439     PISSN: 16632818     EISSN: 16632826     Source Type: Journal    
DOI: 10.1159/000184274     Document Type: Article

References (22)

1. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez LC, Rauh W, Rosier A, Bradlow HL, New MI: A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolism of cortisol. J Clin Endocrinol Metab 1979;49:757–764.
2. Shackleton CHL, Winter JSD, Arteaga E, Lopez JM, Rodriguez J: Congenital 11β-hydroxysteroid-dehydrogenasc deficiency associated with juvenile hypertension: Corticosteroid metabolite profiles of four patients and their families. Clin Endocrinol 1985;22:701–714.
3. Edwards CRW, Stewart PM, Naim IM, Grieve J, Shackleton CHL: Cushing’s disease of the kidney. J Endocrinol 1985;104(suppl):53.
4. Stewart PM, Corrie JET, Shackleton CHL, Edwards CRW: Syndrome of apparent mineralocorticoid excess: a defect in the cortisol-cortisone shuttle. J Clin Invest 1988;82:340–349.
5. Monder C, Stewart PM, Lakshmi V, Valentino R, Burt D, Edwards CWR: Licorice inhibits corticosteroid 11β-dehydrogenaseof rat kidney and liver: In vivo and in vitro studies. Endocrinology 1989;125:1046–1053.
6. Stewart PM, Wallace AM, Valentino R, Burt D, Shacklcton CHL, Edwards CRW: Mineralocorticoid activity of licorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 1987;ii;821–823.
7. Valentino R, Stewart PM, Burt D, Edwards CRW: Liquorice inhibits 11-beta-hydroxysteroid-dehydrogenase in the rat. J Endocrinol 1987;112(suppl):260.
8. Lian C: L’alcoolisme cause de hypertension artériale. Bull Acad Nat Med 1915;74:525–528.
9. Klatsky AL, Friedman GD, Siegclaub AB, Gerard MJ: Alcohol consumption and blood pressure: Kaiser Permanent Multiphasic Health Examination data. N Engl J Med 1977;296: 1194–1200.
10. Saunders JB, Beevers DG, Paton A: Factors influencing blood pressure in chronic alcoholics. Clin Sci 1979;57:295s–298s.
11. MacMahon S: Alcohol consumption and hypertension. Hypertension 1987;9:111–121.
12. Von Bardeleben U, Heuser I, Holsboer F: Human CRH stimulation response during acute withdrawal and after medium-term abstention from alcohol abuse. Psychoncurocndocrinology 1989;14:441–449.
13. Cronholm T, Curstetedt T, Schmidt DN, Sjovall J: Steroid profiles in urine and plasma of alcoholics during withdrawal. Alcohol 1985;2: 677–682.
14. Lieber CS, Teschke R, Hasumura Y, de Carli LM: Differences in hepatic and metabolic changes after acute and chronic alcohol consumption. Fed Proc 1975;34:2060–2074.
15. Teelucksingh S, Mackie ADR, Burt D, McIntyre MA, Brett L, Edwards CRW: Potentiation of hydrocortisone activity in skin by glycyrrhetinic acid. Lancet 1990;335:1060–1063.
16. Edwards CRW, Stewart PM, Burt D, Brett L, McIntyre MA, Sutanto WS, de Kloet ER, Monder C: Localization of 11β-hydroxysteroid dehydrogenase tissue specific protector of miner-alocorticoid receptor. Lancet 1988;ii:986–1002.
17. Edwards CRW, Stewart PM: Alcohol and hypertension. Proc RCP 1989;19:273.
18. Sheppard K, Funder JW: Type I receptors in parotid, colon, and pituitary are aldosterone selective in vivo. Am J Physiol 1987;263:467.
19. Edwards CRW, Burt D, McIntyre MA, De Kloet ER, Stewart PM, Brett L, Sutanto WS, Monder C: Localization of 11β-hydroxysteroid dehydrogenase tissue specific protector of the mineralocorticoid receptor. Lancet 1988;ii:986.
20. Zumoff B, Bradlow HL, Gallacher TF, Hellmann L: Cortisol metabolism in cirrhosis. J Clin Invest 1967;46:1735–1743.
21. Gordon GG, Vittck J, Ho R, Rosenthal WS, Southren AL, Liever CS: Effect of chronic alcohol use on hepatic testosterone 5α-A-ring reductase activity in the baboon. Gastroenterology 1979;77:110.
22. Kiso Y, Tohkin M, Hikino H, Hattori M, Sakamoto T: Liver protective drugs. Mechanism of antihepatotoxic activity of glycyrrhizin: Effect of free radical generation and lipid peroxidation. Planta Med 1984;50:298.